|
Achievements:
Preparation of Protein
Isolate
Defatted flaxseed meal used for
the project was donated by Bioriginal Foods, Saskatoon, Saskatchewan.
Work started on the project in May, 2003 with the hiring of a summer
undergraduate student. Protein isolate was prepared from flaxseed by
using a standard method that involved extraction with dilute alkali,
followed by precipitation of the extracted proteins with dilute acid.
The isolated protein was freeze-dried and contained 86% protein content
from kjeldahl analysis. Due to the nature of flaxseed meal, the yield
of protein isolate was very low (usually about 10-15%), therefore, the
first two months were used essentially to perform routine extraction in
order to obtain enough quantity of protein isolate that will be suitable
for the next step, i.e., enzymatic hydrolysis.
Protein Hydrolysis
The following section deals with
the first objective of the project, which was to prepare short-chain
peptides that are enriched with branched chain amino acids (BCAA). The
flaxseed protein isolate was hydrolyzed sequentially with two types of
enzymes that converted the long-chain proteins into short-chain
peptides. The first step involved hydrolysis with thermolysin for 5 hr
at pH 7.5 followed by a second step that used papain (pH 6.5) for 3 hr.
During the 8 hr hydrolysis period, 2 ml samples were taken every 30 min
and placed in a water bath of 100oC in order to stop the
enzymatic reaction. The 2 ml aliquots were analyzed for free amino
group content using the trinitro-benzene-sulfonic acid method, so that
the rate of enzymatic reaction can be determined. The results of the
free amino group determination showed that the rate of flaxseed protein
hydrolysis by thermolysin was slower than the rate for hydrolysis by
papain. Overall, the level of free amino groups increased, which
indicates that the flaxseed proteins were broken down into smaller
peptides as expected.
After 8 hr of hydrolysis with
the two enzymes, the resultant protein hydrolysate was collected by
centrifugation and freeze-dried. The freeze-dried sample contained both
the desirable (BCAA) and undesirable (aromatic amino acids, AAA)
peptides. Separation of the peptides is currently being performed on a
column packed with activated carbon, which has a very hydrophobic
character. Since the aromatic amino acids are more hydrophobic than the
branched chain amino acids, we optimized the flow-rate. We added acid
to the protein hydrolysate, which makes the AAA more hydrophobic than
the BCAA. We passed the acidic hydrolysate through the activated carbon
column during which majority of the peptides that contain AAA bind to
the column while most of the BCAA-containing peptides did not bind. In
this way the BCAA-containing peptides were separated from the
AAA-containing peptides. We collect flow-through samples from the
column using various flow rates in order to optimize yield and quality
of the BCAA-enriched peptide fraction. Each of the flow-through samples
will be analyzed for amino acid content so that we can quantify the
ratio of BCAA to AAA and determine the Fischer ratio. At this stage of
the project, we have achieved approximately 50% of the first objective.
Peptide Fractionation
We successfully optimized the
fractionation protocol that enabled preparation of peptide fractions
that are almost devoid of aromatic amino acids as shown in the table
below.
|
Sample |
A260 |
A280 |
|
Flaxseed hydrolysate |
0.538 |
0.592 |
|
Fraction 1 |
0.046 |
0.016 |
|
Fraction 2 |
0.012 |
0.006 |
Where A260 and A280
are the ultraviolet absorbance values obtained after samples were
adjusted to the same protein concentration; the higher the value the
more the amount of aromatic amino acids present in the sample. The
flaxseed hydrolysate is the sample obtained after enzymatic hydrolysis
and prior to separation on an activated carbon column. Fractions 1 and
2 are the peptides obtained after the protein hydrolysate was passed
through the column at the optimized flow rates.
Conclusion:
Fraction 1 contains about 5%
while fraction 2 contains about 2% of the amount of aromatic amino acids
(AAA) in the original flaxseed protein. The low levels of AAA mean that
the fractionated peptides may be used to treat encephalopathy (brain
swelling) that is associated with liver diseases. At this stage of the
project, we have achieved approximately 90% of the first objective. To
complete the first objective we need to prepare larger quantities of
fractions 1 and 2 followed by amino acid analysis that will determine
the amount of branched chain amino acids present in the fractions.
Training of Highly Qualified
Personnel:
Vincent Jung (undergraduate
student)
Acknowledgement:
This project was made possible through funding
from the Province of Manitoba and Government of Canada under the
Canada-Manitoba Agri-Food Research and Development Initiative (ARDI).
|